Day One Biopharmaceuticals, Inc. (DAWN) NASDAQ
21.53
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 963.51M |
| Enterprise Value | 769.23M |
| P/E Ratio | -20.74 |
| PEG Ratio | 0.4 |
| Price/Sales Ratio | 14.06 |
| Price/Book Ratio | 5.05 |
| Enterprise/Revenue | 12.84 |
| Enterprise/EBITDA | -16.38 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.68 |
| Operating Margin | -0.81 |
Management Effectiveness
| Return On Assets | -0.21 |
| Return On Equity | -0.23 |
Income Statement
| Revenue | 158.18M |
| Revenue/Share | 1.53 |
| Gross Profit | 140.97M |
| EBITDA | -123.96M |
| Net Income | -107.32M |
| Diluted EPS | -1.04 |
Balance Sheet
| Total Cash | 441.11M |
| Total Cash/Share | 4.27 |
| Total Debt | 2.79M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 8.02 |
| Book Value Per Share | 4.27 |
Price History
| 52-Week Change | 241.75 |
| 52-Week High | 21.53 |
| 52-Week Low | 5.64 |
| Moving Average 50 Days | 18.21 |
| Moving Average 200 Days | 10.72 |
Statistics
| Average Volume | 4.01M |
| Shares Outstanding | 103.33M |
| % Held by Institutions | 83.97 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
